The Latest Breaking News from Medicare

Veterans of previous bipartisan working groups in the Senate have begun talking about the need for fixes to counter future shortfalls.

Monoclonal antibodies have emerged as a powerful tool for reducing hospitalization and death from COVID-19, but recently published studies suggests that the lab-created proteins are going to those who need them less — patients with the fewest chronic conditions — while usage in hospital outpatient clinics has followed a persistent…

The drug industry, patient advocates and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug. They’ve gone as far as to accuse them of tacit racism, ageism and discrimination against the disabled — and hinted at a lawsuit — over the…

WASHINGTON — Advocates on both sides of a debate over dramatically restricting Medicare’s coverage of an expensive and controversial Alzheimer’s treatment are waging competing campaigns to influence a final decision in April.